MCIM
BPMC

Meadow Creek Investment Management’s Blueprint Medicines BPMC Stock Holding History

Meadow Creek Investment Management’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$226K Hold
3,080
– – ﹤0.01% 999
2019
Q2 		$291K Buy
+3,080
New +$254K 0.01% 914

Other funds holding BPMC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Meadow Creek Investment Management's BPMC Position: Q3 2019 in Review

Meadow Creek Investment Management held its Blueprint Medicines (BPMC) position steady in Q3 2019 at 3,080 shares worth $226K. The position accounts for ﹤0.01% of the portfolio, ranked #999.

Meadow Creek Investment Management first reported a position in BPMC in Q2 2019 and has held it in 2 quarters since. The position peaked at $291K in Q2 2019. 220 funds tracked by Wall St. Rank hold BPMC as of Q3 2019.

  • Meadow Creek Investment Management held 3,080 shares of Blueprint Medicines worth $226K as of Q3 2019.
  • Meadow Creek Investment Management left its Blueprint Medicines share count unchanged in Q3 2019.
  • Blueprint Medicines made up ﹤0.01% of Meadow Creek Investment Management's portfolio in Q3 2019, its #999 holding.
  • Meadow Creek Investment Management first reported a position in Blueprint Medicines in Q2 2019 and has held it in 2 quarters since.
  • Meadow Creek Investment Management's Blueprint Medicines position peaked at $291K in Q2 2019.
  • 220 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2019.

Based on Meadow Creek Investment Management's 13F filing for Q3 2019, filed 14 Nov 2019.